Hyalex Orthopaedics, Inc. news
Today we reflect on the growth of Hyalex Orthopaedics over the past 5 years under the leadership of our CEO Mira Sahney. We wish her all the best in her new role. She leaves behind a bright future for Hyalex and our HYALEX Cartilage System. Good luck, Mira!
In the interim, long-time board member and company advisor, Michael Hawkins, PhD, will serve as our President. Meanwhile, our search for a new CEO is underway.
The entire Hyalex Orthopaedics team remotely joined together to consider the challenges of diversity, equity, and inclusion, while working to build and donate more than 20 prosthetic hands with Generus and Hands of Gratitude.
We’re committed to staying connected to the orthopaedic community and making a positive difference however we can to help others
Hyalex was named Emerging MedTech Company of the Year at the 2020 New England Venture Capital Association 2020 NEVYs Awards on December 1st, 2020.
Click here to read more about the event and award recipients.
Hyalex CEO Mira Sahney and co-founder David Myung, MD, PhD presented at the Musculoskeletal New Ventures Conference session 3 held virtually on Friday, November 13th, 2020.
Click here to read more about the event.
Hyalex welcomes executive team member, Chris Cain, serving as Vice President of Clinical and Regulatory Affairs. Chris joins the Hyalex team with an impressive background in leading numerous clinical trials of implanted medical devices and taking innovative technologies through US PMA and international regulatory approvals. Chris provides the experience necessary to bring the HYALEX® Cartilage System into the clinic, both in the U.S. and in other key markets around the world.
<